Pharmaceutical companies and their patent expiries di Henriette van Looveren edito da LAP Lambert Academic Publishing
Alta reperibilità

Pharmaceutical companies and their patent expiries

What do pharmaceuticals do to maintain their sales values?

EAN:

9783659209598

ISBN:

3659209597

Pagine:
72
Formato:
Paperback
Lingua:
Tedesco
Acquistabile con o la

Descrizione Pharmaceutical companies and their patent expiries

Pharmaceutical companies face difficult times when a patent of a brand name drug expires. Brand name drugs often see a large decline in their sales value. This research studies, using five case studies, what pharmaceutical companies do to overcome such a sales decline. The used strategies are evaluated, using sales values, to see whether these strategies work. Pharmaceutical companies have five possible brand extension strategies they can use, namely: Extended release (XR), new indication, second generation, fixed-dose-combination (FDC) and over-the-counter (OTC). Based on the results of this research, the second generation strategy is the most effective strategy pharmaceutical companies can use to overcome patent expiry of their blockbuster brand name drugs.

Spedizione gratuita
€ 51.95
o 3 rate da € 17.32 senza interessi con
Disponibile in 10-12 giorni
servizio Prenota Ritiri su libro Pharmaceutical companies and their patent expiries
Prenota e ritira
Scegli il punto di consegna e ritira quando vuoi

Recensioni degli utenti

e condividi la tua opinione con gli altri utenti